A Tryst of 'blood Pressure Control- Sex- Comorbidities': the Odyssey of Basic Public Health Services in Yunnan in Quest for Truth

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2024 Feb 16

PMID 38365657

Authors

Linhong Pang

Lakshme Kottu

Zihong Guo

Min Ma

Huadan Wang

YaJing Zhao

Mingjing Tang

Yi Shi

Wei Liu

Xia Wu

Junjie Song

Manli Sun

Daphne Merkus

Md Misbahul Ferdous

Liping He

Lin Duo

Affiliations

Soon will be listed here.

Abstract

Background: The Basic Public Health Service (BPHS), a recently announced free healthcare program, aims to combat the most prevalent Noncommunicable Disease-"Hypertension" (HTN)-and its risk factors on a nationwide scale. In China, there is a rife that HTN less impacts women during their lifetime. We, therefore, aimed to evaluate the sex disparity in hypertension patients with comorbidities among south-west Chinese and the contribution of BPHS to address that concern.

Methods: We have opted for a multistage stratified random sampling method to enroll hypertensive patients of 35 years and older, divided them into BPHS and non-BPHS groups. We assessed the sex disparity in HTN patients with four major comorbidities- Dyslipidemia, Diabetes Mellitus (DM), Cardiovascular Disease (CVD), and Chronic Kidney Disease (CKD), and descriptive data were compiled. Odds ratios from logistic regression models estimated the effectiveness of BPHS in the management of HTN with comorbidities.

Results: Among 1521 hypertensive patients,1011(66.5%) were managed in the BPHS group. The proportion of patients who had at least one comorbidity was 70.7% (95% confidence interval [CI]: 66.3-76.8%), patients aged 65 years and older were more likely to have coexisting comorbidities. Participants who received the BPHS showed significant blood pressure (BP) control with two comorbidities (odds ratio [OR] = 2.414, 95% CI: 1.276-4.570), three or more (OR = 5.500, 95%CI: 1.174-25.756). Patients with dyslipidemia and DM also benefited from BPHS in controlling BP (OR = 2.169, 95% CI: 1.430-3.289) and (OR = 2.785, 95%CI: 1.242-6.246), respectively. In certain high-income urban survey centers, there was sex differences in the HTN management provided by BPHS, with men having better BP control rates than women.

Conclusions: Perhaps this is the first study in China to succinctly show the effectiveness and sex disparity regarding "management of hypertensive comorbidities". This supports that the BPHS program plays a pivotal role in controlling BP, therefore should recommend the national healthcare system to give women a foremost priority in BPHS, especially to those from low-socioeconomic and low-scientific literacy regions.

References

Paulsen M, Andersen M, Thomsen J, Schroll H, Larsen P, Lykkegaard J . Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice. J Am Heart Assoc. 2013; 2(1):e004531. PMC: 3603256. DOI: 10.1161/JAHA.112.004531. View

Liang X, Chen J, Liu Y, He C, Li T . The effect of hypertension and diabetes management in Southwest China: a before- and after-intervention study. PLoS One. 2014; 9(3):e91801. PMC: 3954760. DOI: 10.1371/journal.pone.0091801. View

Chen S, Guo L, Wang Z, Mao W, Ge Y, Ying X . Current situation and progress toward the 2030 health-related Sustainable Development Goals in China: A systematic analysis. PLoS Med. 2019; 16(11):e1002975. PMC: 7340487. DOI: 10.1371/journal.pmed.1002975. View

. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022; 102(5S):S1-S127. DOI: 10.1016/j.kint.2022.06.008. View

Li X, Cai L, Cui W, Wang X, Li H, He J . Association of socioeconomic and lifestyle factors with chronic non-communicable diseases and multimorbidity among the elderly in rural southwest China. J Public Health (Oxf). 2019; 42(2):239-246. DOI: 10.1093/pubmed/fdz020. View

. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019; 16(3):182-241. PMC: 6500570. DOI: 10.11909/j.issn.1671-5411.2019.03.014. View

Nilsson P . What is the optimal blood pressure in patients with diabetes mellitus?. Am J Cardiovasc Drugs. 2004; 1(3):173-7. DOI: 10.2165/00129784-200101030-00003. View

Chen L, Tonkin A, Moon L, Mitchell P, Dobson A, Giles G . Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart. Eur J Cardiovasc Prev Rehabil. 2009; 16(5):562-70. DOI: 10.1097/HJR.0b013e32832cd9cb. View

Zhou B . Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002; 15(1):83-96. View

10.

. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304):957-980. PMC: 8446938. DOI: 10.1016/S0140-6736(21)01330-1. View

11.

Schutte A, Srinivasapura Venkateshmurthy N, Mohan S, Prabhakaran D . Hypertension in Low- and Middle-Income Countries. Circ Res. 2021; 128(7):808-826. PMC: 8091106. DOI: 10.1161/CIRCRESAHA.120.318729. View

12.

Li Y, Wang H, Liu K, Lee G, Chan W, Griffiths S . Medication Adherence and Blood Pressure Control Among Hypertensive Patients With Coexisting Long-Term Conditions in Primary Care Settings: A Cross-Sectional Analysis. Medicine (Baltimore). 2016; 95(20):e3572. PMC: 4902400. DOI: 10.1097/MD.0000000000003572. View

13.

Krause T, Lovibond K, Caulfield M, McCormack T, Williams B . Management of hypertension: summary of NICE guidance. BMJ. 2011; 343:d4891. DOI: 10.1136/bmj.d4891. View

14.

Alsaadon H, Afroz A, Karim A, Habib S, Alramadan M, Billah B . Hypertension and its related factors among patients with type 2 diabetes mellitus - a multi-hospital study in Bangladesh. BMC Public Health. 2022; 22(1):198. PMC: 8801099. DOI: 10.1186/s12889-022-12509-1. View

15.

James P, Oparil S, Carter B, Cushman W, Dennison-Himmelfarb C, Handler J . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013; 311(5):507-20. DOI: 10.1001/jama.2013.284427. View

16.

Hoshide S, Kubota K, Kario K . Difference between morning and evening blood pressure at home and nocturnal hypoxia in the general practitioner-based J-HOP study. Hypertens Res. 2022; 46(3):751-755. DOI: 10.1038/s41440-022-01054-4. View

17.

Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W . Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394(10204):1145-1158. PMC: 6891889. DOI: 10.1016/S0140-6736(19)30427-1. View

18.

Skou S, Mair F, Fortin M, Guthrie B, Nunes B, Miranda J . Multimorbidity. Nat Rev Dis Primers. 2022; 8(1):48. PMC: 7613517. DOI: 10.1038/s41572-022-00376-4. View

19.

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

20.

. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018; 15(1):1-29. PMC: 5803534. DOI: 10.11909/j.issn.1671-5411.2018.01.011. View